ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Infectious Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,209Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 198

$3.96M Total Retail Price of All Prescriptions

Rank: 4 out of 198

570 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 570 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

19% of this provider’s 570 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 5,753 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

50% of this provider’s prescriptions were for brand-name drugs, compared to an average of 47%.

Prescription Price

$279 was the average price of a prescription from this provider, compared to $351 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
CRESTOR 671 333 1 14
HYDROCODONE-ACETAMINOPHEN 458 188 S3 2 26
NORVIR 438 26 3 1
ISENTRESS 284 26 4 3
PRAVASTATIN SODIUM 264 156 5 28
LISINOPRIL 260 157 6 6
TRUVADA 255 21 7 2
OMEPRAZOLE 254 124 8 7
ATORVASTATIN CALCIUM 250 182 9 22
NIASPAN 229 106 10 125
ATRIPLA 228 32 11 5
ZOLPIDEM TARTRATE 224 134 12 17
FENOFIBRATE 222 76 13 54
KALETRA 221 0 14 19
AMLODIPINE BESYLATE 218 195 15 12
SIMVASTATIN 205 156 16 9
REYATAZ 202 22 17 8
LEVOTHYROXINE SODIUM 193 139 18 11
VIREAD 181 0 19 31
PREZISTA 177 0 20 4
NEXIUM 170 68 21 40
METFORMIN HCL 169 127 22 15
METOPROLOL TARTRATE 166 86 23 24
EPZICOM 165 12 24 10
ZETIA 161 90 25 70
ZIAGEN 125 0 10 26 109
LYRICA 121 45 27 57
ACYCLOVIR 114 0 28 29
FUROSEMIDE 106 69 29 24
SERTRALINE HCL 106 48 29 46
SULFAMETHOXAZOLE-TRIMETHOPRIM 103 34 31 13
PROAIR HFA 103 14 31 43
AZITHROMYCIN 102 42 33 23
SUSTIVA 102 12 33 56
GABAPENTIN 101 31 35 21
HYDROCHLOROTHIAZIDE 99 43 36 18
LOVAZA 90 40 37 45
TRAMADOL HCL 89 58 38 42
OXYCODONE HCL 88 0 S2 39 97
DIDANOSINE 86 0 10 40 187
MELOXICAM 86 38 40 74
STAVUDINE 86 0 10 40 167
ACTOS 85 55 43 156
EMTRIVA 84 16 44 85
CYMBALTA 83 33 45 119
TRIZIVIR 80 20 46 138
ABACAVIR 78 0 10 47 192
TAMSULOSIN HCL 77 75 48 67
ALENDRONATE SODIUM 77 52 48 32
LUNESTA 71 17 50 159
CYCLOBENZAPRINE HCL 71 23 R 50 84
TRICOR 69 20 52 65
DRONABINOL 68 0 53 61
CLOPIDOGREL 68 44 53 55
INTELENCE 67 0 55 20
LIPITOR 67 50 55 130
CITALOPRAM HBR 67 33 55 49
ANTARA 66 13 58 201
ADVAIR DISKUS 64 24 59 87
WARFARIN SODIUM 61 43 60 51
VIRAMUNE XR 61 0 60 155
CARISOPRODOL 61 0 R 60 121
SELZENTRY 60 0 63 89
IBUPROFEN 58 0 64 35
LOSARTAN POTASSIUM 58 30 64 36
PLAVIX 58 24 64 76
DIOVAN 55 55 67 78
AMITRIPTYLINE HCL 54 13 R 68 75
RANITIDINE HCL 53 30 69 34
TRILIPIX 50 22 70 249
VIRAMUNE 50 0 70 141
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.